NEUROLOGICAL IMPLANTS SHOULD UNDERGO SPECIFIC BIOCOMPATIBILITY TESTS
This article was originally published in The Gray Sheet
Executive Summary
NEUROLOGICAL IMPLANTS SHOULD UNDERGO SPECIFIC BIOCOMPATIBILITY TESTS, FDA's Neurological Devices Advisory Panel suggested during a Sept. 16 meeting in Gaithersburg, Maryland. "The brain has to be looked at for its unique and multiple characteristics," said panel member Roger Contee, MD, Robert Wood Johnson Medical School, New Brunswick, New Jersey. "I think we need to study [implantation] in more detail...because of the very variegated effects" which materials can have on the brain.